Local Heat-Stress as a Mechanism of Hearing Preservation
NCT02872844 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-08-22
Summary
This pilot study plans to determine whether or not local heat-stress as a mechanism can help to preserve hearing in adults treated with Cisplatin.
Conditions
Interventions
- DEVICE
-
ICS AirCal3
Each patient will undergo a 30-minute heat stress to one ear. For randomization, the left ear will be treated in patients with a registration number ending with an odd number and the right for even numbers. An ICS AirCal3 Research Strategy (Otometrics) system attached to an Intel Core 15vPro Thinkpad (IBM) laptop is used within the audiometry department of a separate outpatient clinic. The patients will be reclined and the hot air caloric at 50°C applied by a licensed, unblinded audiologist for 30 minutes. The patients will be allowed to fixate and use whatever means they prefer for entertainment during the intervention.
Sponsors & Collaborators
-
University of Nebraska
lead OTHER
Principal Investigators
-
Paul Judge, MD · University of Nebraska
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-03
- Primary Completion
- 2018-12-13
- Completion
- 2018-12-13
More Related Trials
-
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
NCT04898374 ·Status: RECRUITING ·Phase: PHASE3
-
Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.
NCT01285674 ·Status: UNKNOWN ·Phase: NA
-
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NCT05050162 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
NCT00011999 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.
NCT05936034 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
NCT00001442 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
NCT01369641 ·Status: TERMINATED ·Phase: NA
-
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
NCT03225157 ·Status: COMPLETED
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
NCT00005814 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT
NCT03340896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
NCT00084435 ·Status: WITHDRAWN ·Phase: PHASE2
-
Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN
NCT03880396 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
NCT00113399 ·Status: TERMINATED ·Phase: PHASE3
-
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
NCT00798655 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00002654 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma
NCT05039606 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00265941 ·Status: COMPLETED ·Phase: PHASE3
-
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
NCT00716976 ·Status: COMPLETED ·Phase: PHASE3
-
Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00033449 ·Status: TERMINATED ·Phase: PHASE1
-
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
NCT04291209 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00005035 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
NCT01016561 ·Status: TERMINATED ·Phase: NA
-
Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer
NCT01161498 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00139269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2